Background Concomitant metabolic dysfunction-associated steatotic liver disease (MASLD) is prevalent in patients with chronic ...

London, UK - 3 March, 2026 - Quell Therapeutics Ltd ('Quell”), a leader in developing engineered T-regulatory (Treg) cell therapies for serious medical conditions driven by the immune system, today ...

This article examines how exercise-induced exerkines prevent disease, as well as promote metabolic, cardiovascular, immune, ...

Liver-related side effects have led some analysts to question fenebrutinib’s prospects, even though the drug has now cleared Phase 3 studies in multiple forms of the disease.

On the FDA’s docket this month are two decisions pushed back from 2025, including one for a rare form of obesity and another for dry eye disease.

A woman diagnosed with a rare autoimmune liver disease says being laughed at after her skin turned yellow made living with the condition even more difficult. Lisa Woodcock, 42, was diagnosed with an ...

A drug for advanced prostate cancer has shown "remarkable" results in an early-stage trial, experts have said.

A phase 2 trial showed that combining targeted radiotherapy with PD-1 blockade and a bevacizumab biosimilar can elicit responses in advanced liver cancer.

When Rachael Pickles started experiencing debilitating fatigue in 2024, it often left her at the point of tears.

Liver enzymes help break down food and turn it into energy and nutritional elements, among other things. Elevated levels ...

China NMPA accepts for priority review GSK’s NDA for linerixibat for cholestatic pruritus in patients with primary biliary cholangitis: London, UK Friday, February 27, 2026, 14: ...

Metabolic dysfunction-associated steatotic liver disease (MASLD) can cause more serious liver conditions, such as liver failure. A new study, led by Lund University in Sweden, presents new data that ...